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Abstract
© 2018 Mukhamedshina, Akhmetzyanova, Kostennikov, Zakirova, Galieva, Garanina, Rogozin,
Kiassov and Rizvanov. The use of stem and progenitor cells to restore damaged organs and
tissues, in particular, the central nervous system, is currently considered a most promising
therapy in regenerative medicine. At the same time, another approach aimed at stimulating
regeneration with the use of stem cells encapsulated into a biopolymer matrix and capable of
creating a specific microenvironment for the implanted cells similar to the natural extracellular
matrix is under active development. Here, we study effects of the application of adipose-derived
mesenchymal stem cells (AD-MSCs) combined with a fibrin matrix on post-traumatic reactions in
the spinal cord in rats. The AD-MSC application is found to exert a positive impact on the
functional and structural recovery after spinal cord injury (SCI) that has been confirmed by the
results  of  behavioral/electrophysiological  and  morphometric  studies  demonstrating  reduced
area  of  abnormal  cavities  and  enhanced  tissue  retention  in  the  site  of  injury.
Immunohistochemical and real-time PCR analyses provide evidence that AD-MSC application
decreases the GFAP expression in the area of SCI that might indicate the reduction of astroglial
activation.  Our  results  also  demonstrate  that  AD-MSC  application  contributes  to  marked
upregulation of PDGFßR and HSPA1b mRNA expression and decrease of Iba1 expression at the
site of the central canal. Thus, the application of AD-MSCs combined with fibrin matrix at the
site of SCI during the subacute period can stimulate important mechanisms of nervous tissue
regeneration and should be further developed for clinical applications.
http://dx.doi.org/10.3389/fphar.2018.00343
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